OncoPharm

John Bossaer
  • 0.0(0개의 평가)
  • 과학
  • 매주 업데이트

OncoPharm is a podcast dedicated to all things oncology pharmacy. Most episodes cover updates and recent publications concerning the use of medications in caring for patients with cancer. Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.

  1. FDA Approval Updates Galore

    1일 전

    FDA Approval Updates Galore

    Lots of FDA approval updates to discuss from the past few weeks: -Zongertinib gets approved in 1st line setting for ERBB2 TKD mutated metastatic NSLCLC -Encorafenib approval with cetuximab + FOLFOX -Teclistamab + Daratumumab approved in 2nd line setting for r/r multiple myeloma -Acalabrutinib + venetoclax (but NOT acalabrutinib + venetoclax + obinutuzumab) is approved for CLL Check out the Oncology Insights Newsletter: https://www.kelleycpharmd.com/newsletter-oncopharm

    13분
  2. BR.31 & ASCO GU '26

    3월 5일

    BR.31 & ASCO GU '26

    This week discuss BR.31 trial of adjuvant durvalumab in NSCLC and put it into the context of the positive studies with atezolizumab and pembrolizumab. We also highlight 2 notable presentations at ASCO GU 2026 on perioperative enfortumab vedotin + pembrolizumab in cisplatin-eligible patients with resectable bladder cancer (KEYNOTE-B15) and advjuant pembrolizumab + belzutifan in RCC (LITESPARK-022) Check out the Oncology Insights Newsletter: https://www.kelleycpharmd.com/newsletter-oncopharm

    18분
  3. Rezatapopt and Colchicine for Trametnib/Dabrafenib Pyrexia

    2월 26일

    Rezatapopt and Colchicine for Trametnib/Dabrafenib Pyrexia

    An exciting new drug, rezatapopt, may be effective in restoring p53 activity in cancers - a possible major therapeutic breakthrough. Can colchicine treat pyrexia from tremetinib & dabrafenib use? This case series says - maybe: https://doi.org/10.1007/s00520-019-4654-2 Check out the Oncology Insights Newsletter: https://www.kelleycpharmd.com/newsletter-oncopharm

    16분
  4. Perioperative Enortumab vedotin + Pembrolizumab

    2월 19일

    Perioperative Enortumab vedotin + Pembrolizumab

    The EV-303 trial that led to the FDA approval of perioperative enfortumab vedotin + pembrolizumab in cisplatin-ineligible bladder cancer patients in now published in NEJM. We discuss the results and ponder potential future changes to treating bladder cancer in the future. Urinary diversion surgeries: https://jamanetwork.com/journals/jamaoncology/fullarticle/2842595

    17분
  5. Axi-Cel and 5-FU Label Changes

    2월 12일

    Axi-Cel and 5-FU Label Changes

    We have FDA changes to the labels of Axi-Cel (to allow for its use in primary CNS lymphoma) and 5-flourouracil (pre-treatment DPYD testing). Also, pembrolizumab nets another approval, this time in conjunction with paclitaxel for platinum-resistant ovarian cancer (limited to PD-L1 CPS of 1% of greater)

    13분

  6. 2월 5일

    Core Communication Skills in Chemotherapy Education

    A brief discussion of the Core Communication Skills* and how to incorporate them into a chemotherapy education session. *Rapport Building *Agenda Setting *Information Management *Active Listening *Addressing Feelings *Common Ground

    15분
  7. PATINA

    1월 29일

    PATINA

    Reviewing the hot-off-the press publication of PATINA, palbociclib in HER-2 amplified breast cancer along with endocrine therapy and HER-2 targeted antibodies.

    16분
  8. Sacituzumab govitecan + pembrolizumab and ASCO GI '26

    1월 22일

    Sacituzumab govitecan + pembrolizumab and ASCO GI '26

    We review the recent ASCENT-04/Keynote-D19 publication of sacituzuab govitecan + pembrolizumab for PD-L1 CPS of 10% and above TNBC compared to chemo + pembrolizumab alone. Also, a quick recap of ASCO GI earlier this month with mentions of zanidatamab and zolbetuximab. Finally, a check-in on The Pitt.

    18분
모두 보기(418개)

소개

OncoPharm is a podcast dedicated to all things oncology pharmacy. Most episodes cover updates and recent publications concerning the use of medications in caring for patients with cancer. Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.

정보

  • 제작진
    John Bossaer
  • 방송 연도
    2017년 - 2026년
  • 에피소드
    418
  • 등급
    전체 연령 사용가
  • 저작권
    © All rights reserved
  • 웹사이트 보기
    OncoPharm

좋아할 만한 다른 항목